COVID-19 must catalyse changes to clinical development.

Tytuł:: COVID-19 must catalyse changes to clinical development.
Autorzy:: MacKenzie R
Honig P
Sewards J
Goodwin R
Hellio MP
Źródło:: Nature reviews. Drug discovery [Nat Rev Drug Discov] 2020 Oct; Vol. 19 (10), pp. 653-654.
Typ publikacji:: Wiadomości
Język:: English
Imprint Name(s):: Original Publication: London, UK : Nature Pub. Group, [2002-
MeSH Terms:: Clinical Trials as Topic*
Health Equity*
Coronavirus Infections/*therapy
Pneumonia, Viral/*therapy
COVID-19 ; Coronavirus Infections/prevention & control ; Humans ; Information Dissemination ; Pandemics/prevention & control ; Patient Selection ; Pneumonia, Viral/prevention & control ; Viral Vaccines
References:: Le, T. T. et al. The COVID-19 vaccine development landscape. Nat. Rev. Drug Discov. 19, 305–306 (2020). (PMID: 3227359110.1038/d41573-020-00073-5)
Robertson, A. S. Cloud-based data systems in drug regulation: an industry perspective. Nat. Rev. Drug Discov. 19, 365–366 (2020). (PMID: 3249404610.1038/d41573-019-00193-7)
Substance Nomenclature:: 0 (Viral Vaccines)
Entry Date(s):: Date Created: 20200905 Date Completed: 20201022 Latest Revision: 20210811
Update Code:: 20240104
DOI:: 10.1038/d41573-020-00149-2
PMID:: 32884108
: Periodyk

Informacja